Bhatt, D. L., Szarek, M., Pitt, B., Cannon, C. P., Leiter, L. A., McGuire, D. K., . . . Steg, P. G. (2021). Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease. The New England journal of medicine, 384(2), 129-139. https://doi.org/10.1056/NEJMoa2030186
Citácia podle Chicago (17th ed.)Bhatt, Deepak L., et al. "Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease." The New England Journal of Medicine 384, no. 2 (2021): 129-139. https://doi.org/10.1056/NEJMoa2030186.
Citácia podľa MLA (8th ed.)Bhatt, Deepak L., et al. "Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease." The New England Journal of Medicine, vol. 384, no. 2, 2021, pp. 129-139, https://doi.org/10.1056/NEJMoa2030186.
Upozornenie: Tieto citáce sú generované automaticky. Nemusia byť úplne správne podľa citačných pravidiel..